1-4 of 4
Dong Zheng, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Favorable Inductive Remission Rate of Decitabine Combined Chemotherapy on < 60-Years of Age MDS-like AML in the First Course

Fengqi Liu, MD, Xiuzhen Tong, MD, Zhenhai Zhou, MD, Dong Zheng, MD, Hehua Wang, MD, Junru Liu, MD, Beihui Huang, MD, Chang Su, MD, Waiyi Zou, MD, Duorong Xu, MD, Juan Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2711.
https://doi.org/10.1182/blood-2018-99-113748
Published: 2018
Journal Articles

Bortezomib with Dexamethasone in Newly Diagnosed Patients with Primary Systemic Light Chain Amyloidosis or Multiple Myeloma-Associated AL Amyloidosis

Beihui Huang, M.D., Juan Li, MD, PhD, Junru Liu, M.D., Dong Zheng, MD, PhD, Mei Chen, M.D., Zhenhai Zhou, M.D., Duorong Xu, M.D., Waiyi Zou, M.D.
Journal: Blood
Blood (2012) 120 (21): 5036.
https://doi.org/10.1182/blood.V120.21.5036.5036
Published: 2012
Journal Articles

Hypophosphorylated Retinoic Acid Receptor Alpha Inhibits the Proliferation of Multiple Myeloma Cells

Dong Zheng, MD, PhD, Juan Li, MD, PhD, Guo Xiaojuan, M.D., Zheng Chaoxu, M.D., Zhang Longjuan, M.D.
Journal: Blood
Blood (2012) 120 (21): 4990.
https://doi.org/10.1182/blood.V120.21.4990.4990
Published: 2012
Journal Articles

Safety and Efficacy of Bortezomib and Dexamethasone (BD) in Multiple Myeloma as First-Line, Second-Line or Third-Line Treatment.

Juan Li, MD, Beihui Huang, MD, Ying Zhao, MD, Dong Zheng, MD, Shaokai Luo, MD
Journal: Blood
Blood (2007) 110 (11): 4817.
https://doi.org/10.1182/blood.V110.11.4817.4817
Published: 2007